Robert Frankel, MD
Interventional Cardiology · Brooklyn, NYNPI 1548211329
Payments from drug & device makers
Across 305 payments — averaging $288.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$32K
- AstraZeneca$19K
- Abbott$16K
- Biotronik Inc.$13K
- Boston Scientific$6K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$626
- plus $3K from 19 others
What the payments were for
- Consulting fees$4,8008%
- Speaking & faculty fees$38,57565%
- Travel & lodging$7,04612%
- Food & beverage$8,81815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 106 | $31,551 |
| AstraZeneca | 37 | $18,687 |
| Abbott | 51 | $15,628 |
| Biotronik Inc. | 19 | $12,866 |
| Boston Scientific | 9 | $6,161 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 26 | $626 |
| Edwards Lifesciences | 8 | $551 |
| GE HealthCare | 1 | $490 |
| Philips North America LLC | 5 | $351 |
| Abiomed | 7 | $239 |
| Shockwave Medical, Inc | 5 | $194 |
| Acist Medical Systems, Inc. | 4 | $131 |
| Novo Nordisk | 1 | $125 |
| Penumbra, Inc. | 4 | $98 |
| Johnson & Johnson | 5 | $76 |
| Novartis | 3 | $74 |
| E.r. Squibb & Sons, L.L.C. | 3 | $52 |
| Pfizer | 2 | $40 |
| Irhythm Technologies, Inc. | 2 | $39 |
| Cook Medical LLC | 2 | $38 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| W. L. Gore & Associates, Inc. | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BRILINTA$18,021
- CoreValve Evolut$15,432
- COREVALVE EVOLUT R$11,078
- GENERAL VASCULAR ACCESS$4,800
- GENERAL - THERAPIES$1,031
- TRICLIP$1,017
- ONYX FRONTIER$316
- RESOLUTE ONYX$170
- LUX-Dx Insertable Cardiac Monitor$147
- (9715) Azurion 5 M20$144
- SYMPLICITY G3$144
- (BQ9) Coronary IVUS$142
- OPTIS$129
- Wegovy$125
- ANDEXXA$122
- SYNERGY$118
How this compares
$88,098 in reported general payments places this provider in the 80th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Brooklyn
- Jamie MengBrooklyn$1.8M
- Peter RouvelasBrooklyn$332K
- Yuhei KobayashiBrooklyn$246K
- Martin LeonNew York$13.5M
- David CohenRoslyn$9.8M
- Susheel KodaliNew York$6M
- Mohamed Azeem LatibBronx$4.6M
- Richard ShlofmitzRoslyn$4.5M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.